Signaling through CD5 activates a pathway involving phosphatidylinositol 3-kinase, Vav, and Rac1 in human mature T lymphocytes

Molecular and Cellular Biology

Volumn 18, Issue 3, 1998, Pages 1725-1735

  Gringhuis, Sonja I ^a   De Leij, Lou F M H ^a   Coffer, Paul J ^b   Vellenga, Edo ^a  

^a UNIVERSITY OF GRONINGEN   (Netherlands)

^b UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

CD5 ANTIGEN; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN SUBUNIT;

ARTICLE; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME INHIBITION; ENZYME PHOSPHORYLATION; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; T LYMPHOCYTE; T LYMPHOCYTE ACTIVATION;

EID: 0031936619     PISSN: 02707306     EISSN: None     Source Type: Journal    
DOI: 10.1128/MCB.18.3.1725     Document Type: Article

References (72)

1. Alberola-Ila, J., L. Places, D. A. Cantrell, J. Vives, and F. Lozano. 1992. Intracellular events involved in CD5-induced human T cell activation and proliferation. J. Immunol. 148:1287-1293.
2. al-Shami, A., S. G. Bourgoin, and P. H. Naccache. 1997. Granulocyte-macrophage colony-stimulating factor-activated signaling pathways in human neutrophils. I. Tyrosine phosphorylation-dependent stimulation of phosphatidylinositol 3-kinase and inhibition by phorbol esters. Blood 89:1035-1044.
3. Beyers, A. D., L. L. Spruyt, and A. F. Williams. 1992. Molecular associations between the T-lymphocyte antigen receptor complex and the surface antigens CD2, CD4, or CD8, and CD5. Proc. Natl. Acad. Sci. USA 89:2945-2949.
4. Biancone, L., M. A. Bowen, A. Lim, A. Aruffo, G. Andres, and L. Staraenkovic. 1996. Identification of a novel inducible cell-surface ligand of CD5 on activated lymphocytes. J. Exp. Med. 184:811-819.
5. Bradford, M. M. 1976. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 72:248-254.
6. Brown, E. J., M. W. Albers, T. B. Shin, K. Ichikawa, C. T. Keith, W. S. Lane, and S. L. Schreiber. 1994. A mammalian protein targeted by G1-arresting rapamycin-receptor complex. Nature 369:756-758.
7. Burgering, B. M. T., and P. J. Coffer. 1995. Protein kinase B (c-Akt) in phosphatidylinositol-3-OH kinase signal transduction. Nature 376:599-602.
8. fyn. Proc. Natl. Acad. Sci. USA 89:9311-9315.
9. Bustelo, X. R., S. D. Rubin, K. L. Suen, D. Carrasco, and M. Barbacid. 1993. Developmental expression of the vav protooncogene. Cell Growth Differ. 4:297-308.
10. Cahill, M. A., R. Janknecht, and A. Nordheim. 1996. Signalling pathways: Jack of all cascades. Curr. Biol. 6:16-19.
11. Cerutti, A., L. Trentin, R. Zambello, R. Sancetta, A. Milani, C. Tassinari, F. Adami, C. Agostini, and G. Semenzato. 1996. The CD5/CD72 receptor system is coexpressed with several functionally relevant counterstructures on human B cells and delivers a critical signaling activity. J. Immunol. 157:1854-1862.
12. Ceuppens, J. L., and M. L. Baroja. 1986. Monoclonal antibodies to the CD5 antigen can provide the necessary second signal for activation of isolated resting T cells by solid-phase-bound OKT3. J. Immunol. 137:1816-1821.
13. Clark, E. A., and J. A. Ledbetter. 1994. How B and T cells talk to each other. Nature 367:425-428.
14. Coso, O. A., M. Chiariello, J.-C. Yu, H. Teramoto, P. Crespo, N. Xu, T. Miki, and J. S. Gutkind. 1995. The small GTP-binding proteins Rac1 and Cdc42 regulate the activity of the JNK/SAPK signaling pathway. Cell 81:1137-1146.
15. Crespo, P., X. R. Bustelo, D. S. Aaronson, O. A. Coso, M. Lopez-Barahona, M. Barbacid, and J. S. Gutkind. 1996. Rac-1 dependent stimulation of the JNK/SAPK signaling pathway by Vav. Oncogene 13:455-460.
16. Crespo, P., K. E. Schuebel, A. A. Ostrom, J. S. Gutkind, and X. R. Bustelo. 1997. Phosphotyrosine-dependent activation of Rac-1 GDP/GTP exchange by the vav proto-oncogene product. Nature 385:169-172.
17. Davies, A. A., S. C. Ley, and M. J. Crumpton. 1992. CD5 is phosphorylated on tyrosine after stimulation of the T-cell antigen receptor complex. Proc. Natl. Acad. Sci. USA 89:6368-6372.
18. Dennehy, K. M., R. Broszeit, D. Garnett, G. A. Durrheim, L. L. Spruyt, and A. D. Beyers. 1997. Thymocyte activation induces the association of phosphatidylinositol 3-kinase and pp120 with CD5. Eur. J. Immunol. 27:679-686.
19. 2+/calmodulin-dependent protein kinase IV. Role in transcriptional regulation. J. Biol. Chem. 269:15520-15527.
20. Exley, M., L. Varticovski, M. Peter, J. Sancho, and C. Terhorst. 1994. Association of phosphatidylinositol 3-kinase with a specific sequence of the T cell receptor ζ chain is dependent on T cell activation. J. Biol. Chem. 269:15140-15146.
21. Franke, T. F., D. R. Kaplan, L. C. Cantley, and A. Toker. 1997. Direct regulation of the Akt proto-oncogene product by phosphatidylinositol-3,4-bisphosphate. Science 275:665-668.
22. Franke, T. F., D. R. Kaplan, and L. C. Cantley. 1997. PI3K: downstream AKTion blocks apoptosis. Cell 88:435-437.
23. 2+/calmodulin-dependent kinase type IV is involved in the CD5-mediated signaling pathway in human T lymphocytes. J. Biol. Chem. 272:31809-31820.
24. Gulbins, E., K. M. Coggeshall, G. Baier, S. Katzav, P. Burn, and A. Altman. 1993. Tyrosine kinase-stimulated guanine nucleotide exchange protein. Science 260:822-825.
25. Han, J., B. Das, W. Wei, L. van Aelst, R. D. Mosteller, R. Khosravi-Far, J. K. Westwick, C. J. Der, and D. Broek. 1997. Lck regulates Vav activation of members of the Rho family of GTPases. Mol. Cell. Biol. 17:1346-1353.
26. Hara, K., K. Yonezawa, H. Sakaue, A. Ando, K. Kotani, T. Kitamura, Y. Kitamura, H. Ueda, L. Stephens, T. R. Jackson, P. T. Hawkins, R. Dhand, A. E. Clark, G. D. Holman, M. D. Waterfield, and M. Kasuga. 1994. 1-Phosphatidylinositol 3-kinase activity is required for insulin-stimulated glucose transport but not for RAS activation in CHO cells. Proc. Natl. Acad. Sci. USA 91:7415-7419.
27. Hawkins, P. T., A. Eguinoa, R.-G. Qiu, D. Stokoe, F. T. Cooke, R. Walters, S. Wennström, L. Claesson-Welsh, T. Evans, M. Symons, and L. Stephens. 1995. PDGF stimulates an increase in GTP-Rac via activation of phosphoinositide 3-kinase. Curr. Biol. 5:393-403.
28. Jones, N. H., M. L. Clabby, D. P. Dialynas, H. J. S. Huang, L. A. Herzenberg, and J. L. Strominger. 1986. Isolation of complementary DNA clones encoding the human lymphocyte glycoprotein T1/Leu-1. Nature 323:346-349.
29. Joneson, T., M. McDonough, D. Bar-Sagi, and L. van Aelst. 1996. RAC regulation of actin polymerization and proliferation by a pathway distinct from Jun kinase. Science 274:1374-1376.
30. June, C. H., P. S. Rabinovitch, and J. A. Ledbetter. 1987. CD5 antibodies increase intracellular ionized calcium concentration in T cells. J. Immunol. 138:2782-2792.
31. Katzav, S., J. L. Cleveland, H. E. Heslop, and D. Pulido. 1991. Loss of the amino-terminal helix-loop-helix domain of the vav proto-oncogene activates its transforming potential. Mol. Cell. Biol. 11:1912-1920.
32. Klarlund, J. K., A. Guilherme, J. J. Holik, J. V. Virbasius, A. Chawla, and M. P. Czech. 1997. Signaling by phosphoinositide-3,4,5-trisphosphate through proteins containing pleckstrin and Sec7 homology domains. Science 275:1927-1930.
33. Klippel, A., W. M. Kavanaugh, D. Pot, and L. T. Williams. 1997. A specific product of phosphatidylinositol 3-kinase directly activates the protein kinase Akt through its pleckstrin homology domain. Mol. Cell. Biol. 17:338-344.
34. PAK and the JNK/SAPK MAP kinase cascade. Cell 87:519-529.
35. Ledbetter, J. A., C. H. June, L. S. Grosmaire, and P. S. Rabinovitch. 1987. Crosslinking of surface antigens causes mobilization of intracellular ionized calcium in T lymphocytes. Proc. Natl. Acad. Sci. USA 84:1384-1388.
36. Musacchio, A., T. Gibson, P. Rice, J. Thompson, and M. Saraste. 1993. The PH domain: a common piece in the structural patchwork of signalling proteins. Trends Biochem. Sci. 18:343-348.
37. Nave, B. T., R. J. Haigh, A. C. Hayward, K. Siddle, and P. R. Shepherd. 1996. Compartment specific regulation of phosphoinositide 3-kinase by platelet-derived growth factor and insulin in 3T3-L1 adipocytes. Biochem. J. 318:55-60.
38. Nobes, C. D., P. Hawkins, L. Stephens, and A. Hall. 1995. Activation of the small GTP-binding proteins rho and rac by growth factor receptors. J. Cell Sci. 108:225-233.
39. Okada, T., L. Sakuma, Y. Fukui, O. Hazeki, and M. Ui. 1994. Blockage of chemotactic peptide-induced stimulation of neutrophils by wortmannin as a result of selective inhibition of phosphatidylinositol 3-kinase. J. Biol. Chem 269:3563-3567.
40. Osman, N., S. C. Ley, and M. J. Crumpton. 1992. Evidence for an association between the T cell receptor/CD3 antigen complex and the CD5 antigen in human T lymphocytes. Eur. J. Immunol. 22:2995-3000.
41. 2+/calmodulin-dependent protein kinase (CaM-kinase) IV by CaM-kinase kinase in Jurkat T lymphocytes. J. Biol. Chem. 270:30464-30469.
42. Park, J.-H., K. Kaushansky, and L. Levitt. 1993. Transcriptional regulation of interleukin 3 (IL3) in primary human T lymphocytes. Role of AP-1 and octamer-binding proteins in control of IL3 gene expression. J. Biol. Chem 268:6299-6308.
43. S6K. FEBS Lett. 410:78-82.
44. lck. Mol. Cell. Biol. 14:2862-2870.
45. Rameh, L. E., A.-K. Arvidsson, K. L. Carraway III, A. D. Couvillon, G. Rathbun, A. Crompton, B. VanRenterghem, M. P. Czech, K. S. Ravichandran, S. J. Burakoff, D.-S. Wang, C.-S. Chen, and L. C. Cantley. 1997. A comparative analysis of the phosphoinositide binding specificity of pleckstrin homology domains. J. Biol. Chem. 272:22059-22066.
46. Ramos-Morales, F., B. J. Druker, and S. Fischer. 1994. Vav binds to several SH2/SH3 containing proteins in activated lymphocytes. Oncogene 9:1917-1923.
47. Reif, K., C. D. Nobes, G. Thomas, A. Hall, and D. A. Cantrell. 1996. PI 3-K signals activate a selective subset of Rac/Rho-dependent effector pathways. Curr. Biol. 6:1445-1455.
48. Reif, K., B. M. T. Burgering, and D. A. Cantrell. 1997. Phosphatidylinositol 3-kinase links the interleukin-2 receptor to protein kinase B and p70 S6 kinase. J. Biol. Chem. 272:14426-14433.
49. Ridley, A. J., H. F. Paterson, C. L. Johnston, D. Diekmann, and A. Hall. 1992. The small GTP-binding protein rac regulates growth factor-induced membrane ruffling. Cell 70:401-410.
50. Rudd, C. E., O. Janssen, K. V. S. Prasad, M. Raab, A. da Silva, J. C. Telfer, and M. Yamamoto. 1993. Src-related protein tyrosine kinases and their surface receptors. Biochim. Biophys. Acta 1155:239-266.
51. 2+ -calmodulin-dependent protein kinase Ia kinase. Phosphorylation of threonine 196 is essential for activation. J. Biol. Chem. 270:17616-17621.
52. Shigematsu, H., H. Iwasaki, T. Otsuka, Y. Ohno, F. Arima, and Y. Niho. 1997. Role of the vav proto-oncogene product (Vav) in erythropoietin-mediated cell proliferation and phosphatidylinositol 3-kinase activity. J. Biol. Chem. 272:14334-14340.
53. Songyang, Z., S. E. Shoelson, M. Chaudhuri, G. Gish, T. Pawson, W. G. Haser, F. King, T. Roberts, S. Ratnofsky, R. J. Lechleider, B. G. Neel, R. B. Birge, J. E. Fajardo, M. M. Chou, H. Hanafusa, B. Schaffhausen, and L. C. Cantley. 1993. SH2 domains recognize specific phosphopeptide sequences. Cell 72:767-778.
54. Spertini, F., W. Stohl, N. Ramesh, C. Moody, and R. S. Geha. 1991. Induction of human T cell proliferation by a monoclonal antibody to CD5. J. Immunol. 146:47-52.
55. Tapon, N., and A. Hall. 1997. Rho. Rac and Cdc42 GTPases regulate the organization of the actin cytoskeleton. Curr. Opin. Cell Biol. 9:86-92.
56. Teramoto, H., P. Salem, K. C. Robbins, X. R. Bustelo, and J. S. Gutkind. 1997. Tyrosine phosphorylation of the vav proto-oncogene product links FcεRI to the Rac1-JNK pathway. J. Biol. Chem. 272:10751-10755.
57. Thomas, Y., E. Glickman, J. DeMartino, J. Wang, G. Goldstein, and L. Chess. 1984. Biologic functions of the OKT1 T cell surface antigen. The T1 molecule is involved in helper function. J. Immunol. 133:724-730.
58. Toker, A., and L. C. Cantley. 1997. Signalling through the lipid products of phosphoinositide-3-OH kinase. Nature 387:673-676.
59. 2+/calmodulin-dependent protein kinase cascade. Molecular cloning and expression of calcium/calmodulin-dependent protein kinase kinase. J. Biol. Chem. 270:19320-19324.
60. Tokumitsu, H., and T. R. Soderling. 1996. Requirements for calcium and calmodulin in the calmodulin kinase activation cascade. J. Biol. Chem. 271:5617-5622.
61. Treisman, R. 1996. Regulation of transcription by MAP kinase cascades. Curr. Opin. Cell Biol. 8:205-215.
62. Uddin, S., M. Sweet, O. R. Colamonici, J. J. Krolewski, and L. C. Platanias. 1997. The vav proto-oncogene product (p95vav) interacts with the Tyk-2 protein kinase. FEBS Lett. 403:31-34.
63. Van de Velde, H., H. Hoegen, W. Luo, J. R. Parnes, and K. Thielemans. 1991. The B-cell surface protein CD72/Lyb-2 is the ligand for CD5. Nature 351:662-665.
64. Verweij, C. L., M. Geerts, and L. A. Aarden. 1991. Activation of interleukin-2 gene transcription via the T-cell surface molecule CD228 is mediated through an NF-κB-like response element. J. Biol. Chem. 266:14179-14182.
65. Vlahos, C. J., W. F. Matter, K. Y. Hui, and R. F. Brown. 1994. A specific inhibitor of phosphatidylinositol 3-kinase, 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one (LY294002). J. Biol. Chem. 269:5241-5248.
66. Ward, S. G., A. Wilson, L. Turner, J. Westwick, and D. M. Sansom. 1995. Inhibition of CD28-mediated T cell costimulation by the phosphoinositide 3-kinase inhibitor wortmannin. Eur. J. Immunol. 25:526-532.
67. Ward, S. G., C. H. June, and D. Olive. 1996. PI 3-kinase: a pivotal pathway in T-cell activation? Immunol Today 17:187-197.
68. Weng, W.-K., L. Jarvis, and T. W. LeBien. 1994. Signaling through CD19 activates Vav/Mitogen-activated protein kinase pathway and induces formation of a CD19/Vav/phosphatidylinositol 3-kinase complex in human B cell precursors. J. Biol. Chem. 269:32514-32521.
69. Westwick, J. K., Q. T. Lambert, G. J. Clark, M. Symons, L. van Aelst, R. G. Pestell, and C. J. Der. 1997. Rac regulation of transformation, gene expression, and actin organization by multiple, PAK-independent pathways. Mol. Cell. Biol. 17:1324-1335.
70. vav activity. Mol. Cell. Biol. 15:4337-4346.
71. Wu, J., D. G. Motto, G. A. Koretzky, and A. Weiss. 1996. Vav and SLP-76 interact and functionally cooperate in IL-2 gene activation. Immunity 4:593-602.
72. Zmuidzinas, A., K. Fischer, S. A. Lira, L. Forrester, S. Bryant, A. Bernstein, and M. Barbacid. 1995. The vav proto-oncogene is required early in embryogenesis but not for hematopoietic development in vitro. EMBO J. 14:1-11.